公司资料

MEI Pharma 股价、新闻与催化剂

股票代码:: MEIP
交易所:: NASDAQ
行业:: Biopharma
所在地:: United States

股价为何变动

Current closing-price context is not available for MEIP.

公司概览

业务概览

MEI Pharma was an oncology company focused on targeted cancer therapies before its restructuring and public-market decline. Its story centered on a concentrated development portfolio.

所在地与行业分类

Headquartered in the United States and listed on NASDAQ before restructuring, MEI sat in specialty oncology biotechnology.

商业模式特征

The company depended on clinical data, portfolio management, and strategic capital decisions.

生物医药行业定位

MEI belongs to the historical oncology-biotech category rather than the current live public-company set.

未来催化剂

MEI Pharma’s catalysts are strategic and portfolio-related, with any remaining oncology or capital update doing the work. The company is no longer a clear live-development story.